Taiwan FDA registration 926d90d4eeef4e4954b01208c3c35074

Microtek 2 gram-positive bacterium drug Minka antibiotic-daptomycin

TW: 微鐵克2革蘭氏陽性菌藥敏卡抗生素-達托黴素

Taiwan·Risk Class 2·BIOMERIEUX, INC.·Registered Apr 25, 2013 – Apr 25, 2028Active

Registration details

Analysis ID: 926d90d4eeef4e4954b01208c3c35074
Customs Code: DHA00602467508

Company information

Manufacturer: BIOMERIEUX, INC.
Manufacturer Country: United States
Authorized Representative: Hong Kong Commercial Mérieux S.p.A. Taiwan Branch

Product details

Intended Use: Equipped with Microtek 2 automatic microbial analyzer, the antibiotic susceptibility of staphylococci and enterococci in clinical practice was determined.
Product Type (Level 1): C Immunology and microbiology
Product Type (Level 2): C.1645 Automatic Antibiotic Sensitivity Test System for Short Incubation Period
Import Information: import

Dates and status

Registration Date: Apr 25, 2013
Expiry Date: Apr 25, 2028

About this record

Access comprehensive regulatory information for Microtek 2 gram-positive bacterium drug Minka antibiotic-daptomycin in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 926d90d4eeef4e4954b01208c3c35074 and manufactured by BIOMERIEUX, INC.. The authorized representative in Taiwan is Hong Kong Commercial Mérieux S.p.A. Taiwan Branch.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.